These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27816633)

  • 21. Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
    Braun K; Pochert A; Lindén M; Davoudi M; Schmidtchen A; Nordström R; Malmsten M
    J Colloid Interface Sci; 2016 Aug; 475():161-170. PubMed ID: 27174622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward
    Prinz C; Delgado PR; Eigentler TW; Starke L; Niendorf T; Waiczies S
    MAGMA; 2019 Feb; 32(1):51-61. PubMed ID: 30515642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular redox-activated anticancer drug delivery by functionalized hollow mesoporous silica nanoreservoirs with tumor specificity.
    Luo Z; Hu Y; Cai K; Ding X; Zhang Q; Li M; Ma X; Zhang B; Zeng Y; Li P; Li J; Liu J; Zhao Y
    Biomaterials; 2014 Sep; 35(27):7951-62. PubMed ID: 24930850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facile synthesis of monodisperse of hollow mesoporous SiO2 nanoparticles and in-situ growth of Ag nanoparticles for antibacterial.
    Xu P; Liang J; Cao X; Tang J; Gao J; Wang L; Shao W; Gao Q; Teng Z
    J Colloid Interface Sci; 2016 Jul; 474():114-8. PubMed ID: 27115332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticles for "two color"
    Koshkina O; White PB; Staal AHJ; Schweins R; Swider E; Tirotta I; Tinnemans P; Fokkink R; Veltien A; van Riessen NK; van Eck ERH; Heerschap A; Metrangolo P; Baldelli Bombelli F; Srinivas M
    J Colloid Interface Sci; 2020 Apr; 565():278-287. PubMed ID: 31978790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles.
    Cao X; Deng WW; Fu M; Wang L; Tong SS; Wei YW; Xu Y; Su WY; Xu XM; Yu JN
    Int J Nanomedicine; 2012; 7():753-62. PubMed ID: 22393284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface characteristics.
    Yu T; Hubbard D; Ray A; Ghandehari H
    J Control Release; 2012 Oct; 163(1):46-54. PubMed ID: 22684119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional core–shell silica nanoparticles for highly sensitive (19)F magnetic resonance imaging.
    Matsushita H; Mizukami S; Sugihara F; Nakanishi Y; Yoshioka Y; Kikuchi K
    Angew Chem Int Ed Engl; 2014 Jan; 53(4):1008-11. PubMed ID: 24446255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensing caspase-1 activity using activatable
    Akazawa K; Sugihara F; Minoshima M; Mizukami S; Kikuchi K
    Chem Commun (Camb); 2018 Oct; 54(83):11785-11788. PubMed ID: 30277484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical Applications.
    Croissant JG; Fatieiev Y; Almalik A; Khashab NM
    Adv Healthc Mater; 2018 Feb; 7(4):. PubMed ID: 29193848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silica nanoparticle-based dual imaging colloidal hybrids: cancer cell imaging and biodistribution.
    Lee H; Sung D; Kim J; Kim BT; Wang T; An SS; Seo SW; Yi DK
    Int J Nanomedicine; 2015; 10 Spec Iss(Spec Iss):215-25. PubMed ID: 26357472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium-22-radiolabeled silica nanoparticles as new radiotracer for biomedical applications: in vivo positron emission tomography imaging, biodistribution, and biocompatibility.
    Al Faraj A; Alotaibi B; Shaik AP; Shamma KZ; Al Jammaz I; Gerl J
    Int J Nanomedicine; 2015; 10():6293-302. PubMed ID: 26504381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of protein corona on the transport of molecules into cells by mesoporous silica nanoparticles.
    Paula AJ; Araujo Júnior RT; Martinez DS; Paredes-Gamero EJ; Nader HB; Durán N; Justo GZ; Alves OL
    ACS Appl Mater Interfaces; 2013 Sep; 5(17):8387-93. PubMed ID: 23841723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hollow Mesoporous Silica Nanoparticles with Tunable Structures for Controlled Drug Delivery.
    Li Y; Li N; Pan W; Yu Z; Yang L; Tang B
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2123-2129. PubMed ID: 28004570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymeric Prodrug Grafted Hollow Mesoporous Silica Nanoparticles Encapsulating Near-Infrared Absorbing Dye for Potent Combined Photothermal-Chemotherapy.
    Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Zhao Y
    ACS Appl Mater Interfaces; 2016 Mar; 8(11):6869-79. PubMed ID: 26937591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming acquired drug resistance in colorectal cancer cells by targeted delivery of 5-FU with EGF grafted hollow mesoporous silica nanoparticles.
    Chen L; She X; Wang T; He L; Shigdar S; Duan W; Kong L
    Nanoscale; 2015 Sep; 7(33):14080-92. PubMed ID: 26242620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Manganese oxide-based multifunctionalized mesoporous silica nanoparticles for pH-responsive MRI, ultrasonography and circumvention of MDR in cancer cells.
    Chen Y; Yin Q; Ji X; Zhang S; Chen H; Zheng Y; Sun Y; Qu H; Wang Z; Li Y; Wang X; Zhang K; Zhang L; Shi J
    Biomaterials; 2012 Oct; 33(29):7126-37. PubMed ID: 22789722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Shortwave Infrared Imaging with J-Aggregates Stabilized in Hollow Mesoporous Silica Nanoparticles.
    Chen W; Cheng CA; Cosco ED; Ramakrishnan S; Lingg JGP; Bruns OT; Zink JI; Sletten EM
    J Am Chem Soc; 2019 Aug; 141(32):12475-12480. PubMed ID: 31353894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preparation of Self-Activated Fluorescence Mesoporous Silica Hollow Nanoellipsoids for Theranostics.
    Singh RK; Kim TH; Mahapatra C; Patel KD; Kim HW
    Langmuir; 2015 Oct; 31(41):11344-52. PubMed ID: 26393922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput preparation of hexagonally ordered mesoporous silica and gadolinosilicate nanoparticles for use as MRI contrast agents.
    Tse NM; Kennedy DF; Moffat BA; Kirby N; Caruso RA; Drummond CJ
    ACS Comb Sci; 2012 Aug; 14(8):443-50. PubMed ID: 22676496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.